Massachusetts Financial Services CO Sarepta Therapeutics, Inc. Transaction History

Massachusetts Financial Services CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$93.0 - $171.7 $5.59 Million - $10.3 Million	-60,158 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $112,366 - $179,556	-1,364 Reduced 2.22%	60,158 $5.89 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $1,454 - $2,576	19 Added 0.03%	61,522 $7.94 Million
Q3 2019 Nov 05, 2019	SELL	$72.81 - $156.91 $16,746 - $36,089	-230 Reduced 0.37%	61,503 $4.63 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $6.93 Million - $9.38 Million	61,733 New	61,733 $9.38 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.